Hematology
Inflammation and Autoimmunity
OPZELURA® (ruxolitinib) cream
Efficacy and Safety of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis: Results From TRuE-AD4
Presentation
Phase 2, Double-Blind, Dose-Ranging Study: Ruxolitinib Cream 1.5%, Triamcinolone Cream 0.1%, and Vehicle
Presentation
Long-Term Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis: Results From TRuE-AD1, TRuE-AD2, and TRuE-AD3
Presentation